128 related articles for article (PubMed ID: 23344994)
1. Platelet Reactivity and Intramyocardial Hemorrhage in Patients With ST-Segment Elevation Myocardial Infarction.
Małek ŁA; Kłopotowski M; Śpiewak M; Woźniak K; Waś J; Miśko J; Rużyłło W; Witkowski A
Clin Appl Thromb Hemost; 2014 Jul; 20(5):553-8. PubMed ID: 23344994
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Intramyocardial Hemorrhage After Reperfused ST-Segment Elevation Myocardial Infarction.
Amier RP; Tijssen RYG; Teunissen PFA; Fernández-Jiménez R; Pizarro G; García-Lunar I; Bastante T; van de Ven PM; Beek AM; Smulders MW; Bekkers SCAM; van Royen N; Ibanez B; Nijveldt R
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862937
[TBL] [Abstract][Full Text] [Related]
3. Effects of platelet and inflammatory system activation on outcomes in diabetic patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Kuliczkowski W; Greif M; Gąsior M; Kaczmarski J; Pres D; Poloński L
Kardiol Pol; 2011; 69(6):531-7. PubMed ID: 21678284
[TBL] [Abstract][Full Text] [Related]
4. Incidence, predictors, and prognostic value of intramyocardial hemorrhage lesions in ST elevation myocardial infarction.
Amabile N; Jacquier A; Shuhab A; Gaudart J; Bartoli JM; Paganelli F; Moulin G
Catheter Cardiovasc Interv; 2012 Jun; 79(7):1101-8. PubMed ID: 21805604
[TBL] [Abstract][Full Text] [Related]
5. Platelet effect of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarction.
Kerneis M; Silvain J; Abtan J; Hauguel M; Barthélémy O; Payot L; Brugier D; Galier S; Collet JP; Montalescot G
Arch Cardiovasc Dis; 2015 Oct; 108(10):502-10. PubMed ID: 26113480
[TBL] [Abstract][Full Text] [Related]
6. Dynamic Changes in ST Segment Resolution After Myocardial Infarction and the Association with Microvascular Injury on Cardiac Magnetic Resonance Imaging.
Weaver JC; Ramsay DD; Rees D; Binnekamp MF; Prasan AM; McCrohon JA
Heart Lung Circ; 2011 Feb; 20(2):111-8. PubMed ID: 20943440
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of T
Bulluck H; Rosmini S; Abdel-Gadir A; Bhuva AN; Treibel TA; Fontana M; Gonzalez-Lopez E; Ramlall M; Hamarneh A; Sirker A; Herrey AS; Manisty C; Yellon DM; Moon JC; Hausenloy DJ
J Magn Reson Imaging; 2017 Sep; 46(3):877-886. PubMed ID: 28199043
[TBL] [Abstract][Full Text] [Related]
8. Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction.
Alexopoulos D; Xanthopoulou I; Gkizas V; Kassimis G; Theodoropoulos KC; Makris G; Koutsogiannis N; Damelou A; Tsigkas G; Davlouros P; Hahalis G
Circ Cardiovasc Interv; 2012 Dec; 5(6):797-804. PubMed ID: 23169985
[TBL] [Abstract][Full Text] [Related]
9. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.
Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG
Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966
[TBL] [Abstract][Full Text] [Related]
10. Onset of antiplatelet action with high (100 mg) versus standard (60 mg) loading dose of prasugrel in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: pharmacodynamic study.
Alexopoulos D; Makris G; Xanthopoulou I; Patsilinakos S; Deftereos S; Gkizas V; Perperis A; Karanikas S; Angelidis C; Tsigkas G; Koutsogiannis N; Hahalis G; Davlouros P
Circ Cardiovasc Interv; 2014 Apr; 7(2):233-9. PubMed ID: 24668226
[TBL] [Abstract][Full Text] [Related]
11. Persistent enhanced platelet activation in patients with acute myocardial infarction and coronary microvascular obstruction: clinical implications.
Aurigemma C; Scalone G; Tomai F; Altamura L; De Persio G; Stazi A; Lanza GA; Crea F
Thromb Haemost; 2014 Jan; 111(1):122-30. PubMed ID: 24085158
[TBL] [Abstract][Full Text] [Related]
12. Mean platelet volume is associated with poor postinterventional myocardial blush grade in patients with ST-segment elevation myocardial infarction.
Sarli B; Baktir AO; Saglam H; Arinc H; Kurtul S; Sivgin S; Akpek M; Kaya MG
Coron Artery Dis; 2013 Jun; 24(4):285-9. PubMed ID: 23542159
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage.
Robbers LF; Eerenberg ES; Teunissen PF; Jansen MF; Hollander MR; Horrevoets AJ; Knaapen P; Nijveldt R; Heymans MW; Levi MM; van Rossum AC; Niessen HW; Marcu CB; Beek AM; van Royen N
Eur Heart J; 2013 Aug; 34(30):2346-53. PubMed ID: 23594591
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia and intramyocardial hemorrhage in patients with ST-segment elevation myocardial infarction.
Ota S; Nishiguchi T; Taruya A; Tanimoto T; Ino Y; Katayama Y; Ozaki Y; Satogami K; Tanaka A
J Cardiol; 2022 Nov; 80(5):456-461. PubMed ID: 35750553
[TBL] [Abstract][Full Text] [Related]
15. Effect of Hematologic Parameters on Microvascular Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.
Karahan Z; Uçaman B; Uluğ AV; Aydınalp Ö; Uğurlu M; Çevik K; Kaya İ; Öztürk Ö
Angiology; 2016 Feb; 67(2):151-6. PubMed ID: 26007233
[TBL] [Abstract][Full Text] [Related]
16. Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
Parodi G; Bellandi B; Xanthopoulou I; Capranzano P; Capodanno D; Valenti R; Stavrou K; Migliorini A; Antoniucci D; Tamburino C; Alexopoulos D
Circ Cardiovasc Interv; 2015 Jan; 8(1):. PubMed ID: 25552565
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.
Eitel I; Wöhrle J; Suenkel H; Meissner J; Kerber S; Lauer B; Pauschinger M; Birkemeyer R; Axthelm C; Zimmermann R; Neuhaus P; Brosteanu O; de Waha S; Desch S; Gutberlet M; Schuler G; Thiele H
J Am Coll Cardiol; 2013 Apr; 61(13):1447-54. PubMed ID: 23466078
[TBL] [Abstract][Full Text] [Related]
18. Effect of infarct severity on regional and global left ventricular remodeling in patients with successfully reperfused ST segment elevation myocardial infarction.
Symons R; Masci PG; Goetschalckx K; Doulaptsis K; Janssens S; Bogaert J
Radiology; 2015 Jan; 274(1):93-102. PubMed ID: 25207466
[TBL] [Abstract][Full Text] [Related]
19. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.
Palmerini T; Calabrò P; Piscione F; De Servi S; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Barozzi C; Tomasi L; Della Riva D; Mariani A; Taglieri N; Reggiani LB; Bianchi R; De Rosa R; Mariani M; Podda G; Généreux P; Stone GW; Angiolillo DJ
JACC Cardiovasc Interv; 2014 Oct; 7(10):1117-27. PubMed ID: 25240538
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular magnetic resonance-derived intramyocardial hemorrhage after STEMI: Influence on long-term prognosis, adverse left ventricular remodeling and relationship with microvascular obstruction.
Husser O; Monmeneu JV; Sanchis J; Nunez J; Lopez-Lereu MP; Bonanad C; Chaustre F; Gomez C; Bosch MJ; Hinarejos R; Chorro FJ; Riegger GA; Llacer A; Bodi V
Int J Cardiol; 2013 Sep; 167(5):2047-54. PubMed ID: 22682700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
